Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
advocacy, arbitrary, AstraZeneca, awaiting, Boehringer, Bridge, carryback, certainty, Coinsurance, Dakota, delist, delisted, delisting, effectuated, eleven, ELREXFIO, foundation, Gaza, Ingelheim, Janssen, Jersey, KPTI, Nevada, Nordisk, North, Novo, Palestinian, PAP, PhRMA, realize, Strip, strong, structure, substantive, suggested, Switzerland, symbol, TALVEY, territory, Wisconsin, York
Removed:
ASC, excluding, prioritization, Virginia
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view